Kolapol KP

Form of release

Kolapol KP (10 fragments 20x8x7mm)
Kolapol KP L contains lincomycin (10 fragments 20x8x7mm)
Kolapol KP M contains metronidazole (10 fragments 20x8x7mm)
Kolapol KP LM contains lincomycin and metronidazole (10 fragments 20x8x7mm)
Kolapol KP (4 fragments 10x10x7mm)
Kolapol KP L contains lincomycin (4 fragments 10x10x7mm)
Kolapol KP M contains metronidazole (4 fragments. 10x10x7xmm)
Kolapol KP LM contains lincomycin and metronidazole (4 fragments 10x10x7 mm)
Kolapol KP (20 fragments 10x10x7 mm)
Kolapol KP LM contains lincomycin and metronidazole (20 fragments 10x10x7 mm)

Where it is applied

Properties.
It is a composition of organic and inorganic components of solid tissues. It is characterized by biocompatibility with human tissues and does not cause a rejection reaction. COLAPOL KP enhances osteogenesis (significantly less than COLAPOL KP-3) and has a powerful local hemostatic effect.

Indications for use.
In surgical and orthopedic-traumatological practice: stopping bleeding in bone tissues, during surgical intervention, as well as in open wounds of traumatic origin, during operations on various hemangiomas, including in patients with hemophilia.
In ENT surgery, it is used to stop bleeding in the Kesselbach plexus area in cases of trauma and hypertension, as well as during surgeries such as conchotomy, etc.
In dental practice, COLAPOL KP is indicated for increased bleeding (after complex tooth extraction, dental implantation, and other surgical procedures).

It may contain antibacterial/antimicrobial components